About VIVEX Biologics
We are the regenerative medicine company that develops and delivers innovative allograft solutions designed to support the body’s healing and regenerative potential, ultimately improving patient outcomes and quality of life.
The underpinnings of our regenerative medicine solutions technology date back 50 years to the founding of The University of Miami Tissue Bank in 1970. We experienced multiple firsts in clinical and scientific achievement leading up to 2014, when VIVEX acquired the University of Miami Tissue Bank. This acquisition streamlined our strategic plan to focus on new regenerative medicine solutions, research and development, expansion of manufacturing capabilities, and sales and marketing efforts.
|
|
|
51-200 employees
View all VIVEX Biologics employees
|
|
Biotechnology
|
|
2430 NW 116th St, Miami, Florida 33167, US
|
VIVEX Biologics Alternatives
Frequently Asked Questions about VIVEX Biologics
Peter Wehrly is the CEO of VIVEX Biologics. To contact Peter Wehrly email at [email protected], [email protected] or [email protected].
The decision makers in VIVEX Biologics are Brian Fromhold, Craig Sincaglia, Drew Lindemann, etc. Click to Find VIVEX Biologics decision makers emails.
VIVEX Biologics Staff Directory
Search VIVEX Biologics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
